These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16286361)

  • 21. In vitro interference of tigecycline at subinhibitory concentrations on biofilm development by Enterococcus faecalis.
    Maestre JR; Aguilar L; Mateo M; Giménez MJ; Méndez ML; Alou L; Granizo JJ; Prieto J
    J Antimicrob Chemother; 2012 May; 67(5):1155-8. PubMed ID: 22323499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation.
    Kronvall G; Karlsson I; Walder M; Sörberg M; Nilsson LE
    J Antimicrob Chemother; 2006 Mar; 57(3):498-505. PubMed ID: 16410264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; López F; Alvarez J; Picazo JJ;
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004-2007).
    Seifert H; Dowzicky MJ
    Chemotherapy; 2009; 55(4):241-52. PubMed ID: 19468222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.
    Liao CH; Kung HC; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Cheng YJ; Lin HC; Shi ZY; Wang LS; Chuang YC; Tsao SM; Lu CT; Liu JW; Huang CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S192-6. PubMed ID: 19013354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):300-4. PubMed ID: 19501791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efflux pumps may play a role in tigecycline resistance in Burkholderia species.
    Rajendran R; Quinn RF; Murray C; McCulloch E; Williams C; Ramage G
    Int J Antimicrob Agents; 2010 Aug; 36(2):151-4. PubMed ID: 20399621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of tigecycline and ertapenem against clinical isolates of Brucella melitensis detected by E-test on different media.
    Tanyel E; Coban AY; Fisgin NT; Tulek N
    Indian J Med Microbiol; 2010; 28(4):370-1. PubMed ID: 20966572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.
    Koeth LM; King A; Knight H; May J; Miller LA; Phillips I; Poupard JA
    J Antimicrob Chemother; 2000 Sep; 46(3):369-76. PubMed ID: 10980162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains.
    Katsandri A; Avlamis A; Pantazatou A; Petrikkos GL; Legakis NJ; Papaparaskevas J;
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):231-6. PubMed ID: 16626904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.
    Sotto A; Bouziges N; Jourdan N; Richard JL; Lavigne JP
    Pathol Biol (Paris); 2007 Nov; 55(8-9):398-406. PubMed ID: 17905534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.
    Moet GJ; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):333-6. PubMed ID: 16989974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of medium composition on bacterial susceptibility testing to gentamicin and netilmicin.
    Dornbusch K
    Scand J Infect Dis Suppl; 1980; Suppl 23():46-53. PubMed ID: 6937968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
    Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
    Bebear C; Cantet P; Renaudin H; Quentin C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):577-80. PubMed ID: 3937130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.